Evaluation of gastrointestinal transit in clinical practice: Position paper of the American and European Neurogastroenterology and Motility Societies

Neurogastroenterology and Motility

Volumn 23, Issue 1, 2011, Pages 8-23

  Rao, S S C ^a   Camilleri, M ^b   Hasler, W L ^c   Maurer, A H ^d   Parkman, H P ^d   Saad, R ^c   Scott, M S ^e   Simren, M ^f   Soffer, E ^g   Szarka, L ^b  

^a UNIVERSITY OF IOWA   (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^f UNIVERSITY OF GOTHENBURG   (Sweden)

^g CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Breath tests; Dysmotility; Gastrointestinal transit; Radioopaque markers; Scintigraphy; Wireless motility capsule

Indexed keywords

ABDOMINAL RADIOGRAPHY; BREATH ANALYSIS; CLINICAL PRACTICE; ECHOGRAPHY; GASTROINTESTINAL MOTILITY DISORDER; GASTROINTESTINAL TRACT SCINTISCANNING; GASTROINTESTINAL TRANSIT; MEDICAL SOCIETY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; STOMACH EMPTYING; STOMACH MOTILITY;

BREATH TESTS; CAPSULE ENDOSCOPY; CONSTIPATION; CONTRAST MEDIA; GASTRIC EMPTYING; GASTROINTESTINAL TRANSIT; GASTROPARESIS; HUMANS; RADIONUCLIDE IMAGING; SOCIETIES;

EID: 78650154193     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/j.1365-2982.2010.01612.x     Document Type: Review

References (97)

1. Abell T, Camilleri M, Donohoe K et al. Consensus recommendations for gastric emptying scintigraphy: a joint report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine. Am J Gastroenterol 2007; 102: 1-11.
2. Bonapace ES, Maurer AH, Davidoff S, Krevsky B, Fisher RS, Parkman HP. Whole gut transit scintigraphy in the clinical evaluation of patients with upper and lower gastrointestinal symptoms. Am J Gastroenterol 2000; 95: 2838-47.
3. Couturier O, Bodet-Milin C, Querellou S, Carlier T, Turzo A, Bizais Y. Gastric scintigraphy with a liquid-solid radiolabelled meal: performances of solid and liquid parameters. Nucl Med Commun Nov 2004; 25: 1143-50.
4. Ziessman H, Ankit C, Clarke J, Ramos A, Wahl R. The added value of liquid gastric emptying compared with solid emptying alone. J Nucl Med 2009; 50: 726-31.
5. Datz F, Christian P, Moore J. Gender-related differences in gastric emptying. J Nucl Med 1987; 28: 1204-7.
6. Gill R, Murphy P, Hooper H, Bowes K, Kingma Y. Effect of the menstrual cycle on gastric emptying. Digestion 1987; 36: 168-74.
7. Knight LC, Parkman HP, Brown KL et al. Delayed gastric emptying and decreased antral contractility in normal premenopausal women compared with men. Am J Gastroenterol 1997; 92: 968-75.
8. Cremonini F, Delgado-Aros S, Talley NJ. Functional dyspepsia: drugs for new (and old) therapeutic targets. Baillieres Best Pract Res Clin Gastroenterol 2004; 18: 717-33.
9. Guo JP, Maurer AH, Fisher RS, Parkman HP. Extending gastric emptying scintigraphy from two to four hours detects more patients with gastroparesis. Dig Dis Sci 2001; 46: 24-9.
10. Camilleri M, Malagelada JR, Brown ML, Becker G, Zinsmeister AR. Relation between antral motility and gastric emptying of solids and liquids in humans. Am J Physiol 1985; 245: G580-5.
11. Collins PJ, Horowitz M, Chatterton BE. Proximal, distal and total stomach emptying of a digestible solid meal in normal subjects. Br J Radiol 1988; 61: 12-8.
12. Urbain JL, Siegel JA, Charkes ND, Maurer AH, Malmud LS, Fisher RS. The two-component stomach: effects of meal particle size on fundal and antral emptying. Eur J Nucl Med 1989; 15: 254-9.
13. Camilleri M, Zinsmeister AR, Greydanus MP, Brown ML, Proano M. Towards a less costly but accurate test of gastric emptying and small bowel transit. Dig Dis Sci 1991; 36: 609.
14. Ziessman H, Bonta D, Goetze S, Ravich W. Experience with a simplified, standardized 4-hour gastric-emptying protocol. J Nucl Med 2007; 48: 568-72.
15. Choi MG, Camilleri M, Burton DD et al. [13C]octanoic acid breath test for gastric emptying of solids: accuracy, reproducibility, and comparison with scintigraphy. Gastroenterology 1997; 112: 1155-62.
16. Lee JS, Camilleri M, Zinsmeister AR et al. Toward office-based measurement of gastric emptying in symptomatic diabetics using [13C]octanoic acid breath test. Am J Gastroenterol 2000; 95: 2751-61.
17. Corinaldesi R, Stanghellini V, Raiti C et al. Effect of chronic administration of cisapride on gastric emptying of a solid meal and on dyspeptic symptoms in patients with idiopathic gastroparesis. Gut 1987; 28: 300-5.
18. Jiian R, Ducrot F, Ruskone A et al. Symptomatic, radionuclide and therapeutic assessment of chronic idiopathic dyspepsia. A double-blind placebo-controlled evaluation of cisapride. Dig Dis Sci 1989; 34: 657-64.
19. Janssens J, Peeters TL, Vantrappen G et al. Improvement of gastric emptying in diabetic gastroparesis by erythromycin. Preliminary studies. N Engl J Med 1990; 322: 1028-31.
20. Prather CM, Camilleri M, Thomforde GM, Forstrom LA, Zinsmeister AR. Gastric axial forces in experimentally delayed and accelerated gastric emptying. Am J Physiol 1993; 264: G928-34.
21. Parkman HP, Gonlachanvit S, Hsu C-W et al. Effect of altering gastric emptying on postprandial glucose following a physiologic meal in type II diabetic patients. Dig Dis Sci 2003; 48: 488-97.
22. Camilleri M. Diabetic gastroparesis. N Engl J Med 2007; 356: 820-9.
23. Horowitz M, Harding P, Chatterton B, Collins P, Shearman D. Acute and chronic effects of domperidone on gastric emptying in diabetic autonomic neuropathy. Dig Dis Sci 1985; 30: 1-9.
24. Tack J, Bisschops R, Sarnelli G. Pathophysiology and treatment of functional dyspepsia. Gastroenterology 2004; 127: 1239-55.
25. Bredenoord AJ, Chial HJ, Camilleri M, Mullan BP, Murray JA. Gastric accommodation and emptying in evaluation of patients with upper gastrointestinal symptoms. Clin Gastroenterol Hepatol 2003; 1: 264-72.
26. Kuo B, McCallum RW, Koch KL et al. Comparison of gastric emptying of a nondigestible capsule to a radio-labelled meal in healthy and gastroparetic subjects. Aliment Pharmacol Ther 2008; 27: 186-96.
27. Rao SS, Kuo B, McCallum RW et al. Investigation of Colonic and Whole Gut Transit with Wireless Motility Capsule and Radioopaque Markers in Constipation. Clin Gastroenterol Hepatol 2009; 7: 537-44.
28. Sarosiek I, Selover KH, Katz LA et al. The assessment of regional gut transit times in healthy controls and patients with gastroparesis using wireless motility technology. Aliment Pharmacol Ther 2010; 31: 313-22.
29. Cassilly D, Kantor S, Knight LC et al. Gastric emptying of a non-digestible solid: assessment with simultaneous SmartPill pH and pressure capsule, antroduodenal manometry, gastric emptying scintigraphy. Neurogastroenterol Motil 2008; 20: 311-9.
30. Mreyoud A, Rozov I, Moore J et al. Assessment of drug effects on gastric emptying and contractility using wireless capsule manometry. Gastroenterology 2009; 136(Suppl 1): T1271.
31. Hasler WL, Saad RJ, Rao SS et al. Heightened colon motor activity measured by a wireless capsule in patients with constipation: relation to colon transit and IBS. Am J Physiol Gastrointest Liver Physiol 2009; 297: G1107-14.
32. Kloetzer L, Chey WD, McCallum RW et al. Motility of the antroduodenum in healthy and gastroparetics characterized by wireless motility capsule. Neurogastroenterol Motil 2010; 22: 527-33, e117.
33. Ghoos YF, Maes BD, Geypens BJ et al. Measurement of gastric emptying rate of solids by means of a carbon labeled octanoic acid breath test. Gastroenterology 1994; 104: 1640-7.
34. Szarka LA, Camilleri M, Vella A et al. A stable isotope breath test with a standard meal for abnormal gastric emptying of solids in the clinic and in research. Clin Gastroenterol Hepatol 2008; 6: 635-43.
35. [C13]-Spirulina platensis Gastric Emptying Breath Test (GEBT): Investigator Brochure. Brentwood, TN: Advanced Breath Diagnostics, LLC, 2005.
36. Schadewaldt P, Schommartz B, Wienrich G et al. Application of isotope-selective nondispersive infrared spectrometry (IRIS) for evaluation of [13C]octanoic acid gastric-emptying breath tests: comparison with isotope ratio-mass spectrometry (IRMS). Clin Chem 1997; 43: 518-22.
37. Viramontes BE, Kim D-Y, Camilleri M et al. Validation of a stable isotope gastric emptying test for normal, accelerated or delayed gastric emptying. Neurogastroenterol Motil 2001; 13: 567-74.
38. Sanaka M, Urita Y, Sugimoto M, Yamamoto T, Kuyama Y. Comparison between gastric scintigraphy and the [13C]-acetate breath test with Wagner-Nelson analysis in humans. Clin Exp Pharmacol Physiol 2006; 33: 1239-43.
39. Odunsi ST, Camilleri M, Szarka LA, Zinsmeister AR. Optimizing analysis of stable isotope breath tests to estimate gastric emptying of solids. Neurogastroenterol Motil 2009; 21: 706-e387.
40. Choi MG, Camilleri M, Burton DD et al. Reproducibility and simplification of 13C-octanoic acid breath test for gastric emptying of solids. Am J Gastroenterol 1998; 93: 92-8.
41. Vella A, Lee JS, Camilleri M et al. Effects of pramlintide, an amylin analogue, on gastric emptying in type 1 and 2 diabetes mellitus. Neurogastroenterol Motil 2002; 14: 123-31.
42. Keller J, Andresen V, Wolter J, Layer P, Camilleri M. Influence of clinical parameters on the results of 13C-octanoic acid breath tests: examination of different mathematical models in a large patient cohort. Neurogastroenterol Motil 2009; 21: 1039-e83.
43. Van De Casteele M, Luypaerts A, Geypens B et al. Oxidative breakdown of octanoic acid is maintained in patients with cirrhosis despite advanced disease. Neurogastroenterol Motil 2003; 15: 113-20.
44. Jones KL, O'Donovan D, Horowitz M et al. Effects of posture on gastric emptying, transpyloric flow, and hunger after a glucose drink in healthy humans. Dig Dis Sci 2006; 51: 1331-8.
45. Gentilcore D, Hausken T, Horowitz M, Jones KL. Measurements of gastric emptying of low- and high-nutrient liquids using 3D ultrasonography and scintigraphy in healthy subjects. Neurogastroenterol Motil 2006; 18: 1062-8.
46. Fidler J, Bharucha AE, Camilleri M et al. Application of magnetic resonance imaging to measure fasting and postprandial volumes in humans. Neurogastroenterol Motil 2009; 21: 42-51.
47. Simren M, Stotzer PO. Use and abuse of hydrogen breath tests. Gut 2006; 55: 297-303.
48. 2 breath test as a measure of mouth to cecum transit time. Gut 1983; 24: 893-6.
49. Miller MA, Parkman HP, Urbain JL et al. Comparison of scintigraphy and lactulose breath hydrogen test for assessment of orocecal transit: lactulose accelerates small bowel transit. Dig Dis Sci 1997; 42: 10-8.
50. Geypens B, Bennink R, Peeters M et al. Validation of the lactose-[13C]ureide breath test for determination of orocecal transit time by scintigraphy. J Nucl Med 1999; 40: 1451-5.
51. Morrison DJ, Dodson B, Preston T, Weaver LT. Gastrointestinal handling of glycosyl [13C]ureides. Eur J Clin Nutr 2003; 57: 1017-24.
52. Krevsky B, Maurer AH, Niewiarowski T, Cohen S. Effect of verapamil on human intestinal transit. Dig Dis Sci 1992; 37: 919-24.
53. Charles F, Camilleri M, Phillips SF, Thomforde GM, Forstrom LA. Scintigraphy of the whole gut: clinical evaluation of transit disorders. Mayo Clin Proc 1995; 70: 113-8.
54. Argenyi EE, Soffer EE, Madsen MT, Berbaum KS, Walkner WO. Scintigraphic evaluation of small bowel transit in healthy subjects: inter- and intrasubject variability. Am J Gastroenterol 1995; 90: 938-42.
55. Camilleri M, Hasler WL, Parkman HP, Quigley EM, Soffer E. Measurement of gastrointestinal motility in the GI laboratory. Gastroenterology 1998; 115: 747-62.
56. Maurer AH, Krevsky B. Whole-gut transit scintigraphy in the evaluation of small-bowel and colonic transit disorders. Semin Nucl Med 1995; 25: 326-38.
57. Grybäck P, Jacobsson H, Blomquist L, Schnell PO, Hellström PM. Scintigraphy of the small intestine: a simplified standard for study of transit with reference to normal values. Eur J Nucl Med Mol Imaging 2002; 29: 39-44.
58. Bennink R, Peeters M, Van den Maegdenbergh V et al. Evaluation of small-bowel transit for solid and liquid test meal in healthy men and women. Eur J Nucl Med 1999; 26: 1560-6.
59. Deiteren A, Camilleri M, Bharucha AE et al. Performance characteristics of scintigraphic colon transit measurement in health and irritable bowel syndrome and relationship to bowel functions. Neurogastroenterol Motil 2010; 22: 415-23, e95.
60. Camilleri M, Brown ML, Malagelada JR. Impaired transit of chyme in chronic intestinal pseudoobstruction. Correction by cisapride. Gastroenterology 1986; 91: 619-26.
61. Camilleri M, Malagelada JR, Abell TL et al. Effect of six weeks of treatment with cisapride in gastroparesis and intestinal pseudoobstruction. Gastroenterology 1989; 96: 704-12.
62. Prather CM, Camilleri M, Zinsmeister AR, McKinzie S, Thomforde G. Tegaserod accelerates orocecal transit in patients with constipation-predominant irritable bowel syndrome. Gastroenterology 2000; 118: 463-8.
63. Balan K, Alwis L, Sonoda LI et al. Utility of whole gut transit scintigraphy in patients with chronic gastrointestinal symptoms. Nucl Med Commun 2010; 31: 328-33.
64. Camilleri M, Thorne NK, Ringel Y et al. Wireless pH-motility capsule for colonic transit: prospective comparison with radiopaque markers in chronic constipation. Neurogastroenterol Motil 2010; 22: 874-82.
65. Connell AM, McCall J, Misiewicz JJ, Rowlands EN. Observations on the clinical use of radio pills. Br Med J 1963; 2: 771-4.
66. Evans DF, Pye G, Bramley R, Clark AG, Dyson TJ, Hardcastle JD. Measurement of gastrointestinal pH profiles in normal ambulant human subjects. Gut 1988; 29: 1035-41.
67. Zarate N, Mohammed S, O'Shaughnessy E et al. Accurate localisation of a fall in pH within the ileo-caecal region. Neurogastroenterol Motil 2009; 21(Suppl 1): 43. (abstract).
68. Sarosiek I, Sarosiek J, Rao S et al. Comparisons of alimentary tract transit times among normal subjects from two multicentre trials using SmartPill wireless pH/pressure recording capsule: its clinical implications. Am J Gastroenterol 2007; 102(Suppl 2): S170.
69. Rao SS, Mysore KR, Attaluri A, Valestin J. Diagnostic utility of wireless motility capsule in gastrointestinal dysmotility. J Clin Gastroenterol 2011. (in press).
70. De Iorio F, Malagelada C, Azpiroz F et al. Intestinal motor activity, endoluminal motion and transit. Neurogastroenterol Motil 2009; 21: 1264-71.
71. Stathopoulos E, Schlageter V, Meyrat B, Ribaupierre Y, Kucera P. Magnetic pill tracking: a novel non-invasive tool for investigation of human digestive motility. Neurogastroenterol Motil 2005; 17: 148-54.
72. Hinton JM, Lennard-Jones JE, Young AC. A new method for studying gut transit times using radioopaque markers. Gut 1969; 10: 842-7.
73. Abrahamsson H, Antov S, Bosaeus I. Gastrointestinal and colonic segmental transit time evaluated by a single abdominal x-ray in healthy subjects and constipated patients. Scand J Gastroenterol 1988; 152: 72-80.
74. Chaussade S, Khyari A, Roche H et al. Determination of total and segmental colonic transit time in constipated patients Results in 91 patients with a new simplified method. Dig Dis Sci 1989; 34: 1168-72.
75. Metcalf AM, Phillips SF, Zinsmeister AR et al. Simplified assessment of segmental colonic transit. Gastroenterology 1987; 92: 40-7.
76. Sadik R, Abrahamsson H, Stotzer PO. Gender differences in gut transit shown with a newly developed radiological procedure. Scand J Gastroenterol 2003; 38: 36-42.
77. Southwell BR, Clarke MC, Sutcliffe J, Hutson JM. Colonic transit studies: normal values for adults and children with comparison of radiological and scintigraphic methods. Pediatr Surg Int 2009; 25: 559-72.
78. Pomerri F, Frigo AC, Grigoletto F et al. Error count of radiopaque markers in colonic segmental transit time study. Am J Roentgenol 2007; 189: W56-9.
79. Van Der Sijp JR, Kamm MA, Nightingale JM et al. Radioisotope determination of regional colonic transit in severe constipation: comparison with radio opaque markers. Gut 1993; 34: 402-8.
80. Corazziari E, Badiali D, Habib FI et al. Small volume isosmotic polyethylene glycol electrolyte balanced solution (PMF-100) in treatment of chronic nonorganic constipation. Dig Dis Sci 1996; 41: 1636-42.
81. Harish K, Hazeena K, Thomas V et al. Effect of tegaserod on colonic transit time in male patients with constipation-predominant irritable bowel syndrome. J Gastroenterol Hepatol 2007; 22: 1183-9.
82. Sloots CE, Poen AC, Kerstens R et al. Effects of prucalopride on colonic transit, anorectal function and bowel habits in patients with chronic constipation. Aliment Pharmacol Ther 2002; 16: 759-67.
83. Rao SSC, Mudipalli RS, Stessman M et al. Investigation of the utility of colorectal function tests and Rome II criteria in dyssynergic defecation (Anismus). Neurogastroenterol Motil 2004; 16: 1-8.
84. Sadik R, Abrahamsson H, Ung KA, Stotzer PO. Accelerated regional bowel transit and overweight shown in idiopathic bile acid malabsorption. Am J Gastroenterol 2004; 99: 711-8.
85. Camilleri M. Scintigraphic biomarkers for colonic dysmotility. Clin Pharmacol Ther 2010; 87: 748-53.
86. Proano M, Camilleri M, Phillips SF et al. Transit of solids through the human colon: regional quantification in the unprepared bowel. Am J Physiol 1990; 258: G856.
87. Camilleri M, Zinsmeister AR. Towards a relatively inexpensive, noninvasive, accurate test for colonic motility disorders. Gastroenterology 1992; 103: 36.
88. Lundin E, Graf W, Garske U, Nilsson S, Maripuu E, Karlbom U. Segmental colonic transit studies: comparison of a radiological and a scintigraphic method. Colorectal Dis 2007; 9: 344-51.
89. Cremonini F, Mullan BP, Camilleri M et al. Performance characteristics of scintigraphic transit measurements for studies of experimental therapies. Aliment Pharmacol Ther 2002; 16: 1781-90.
90. Manabe N, Wong BS, Camilleri M et al. Lower functional gastrointestinal disorders: evidence of abnormal colonic transit in a 287 patient cohort. Neurogastroenterol Motil 2010; 22: 293-e82.
91. Stivland T, Camilleri M, Vassallo M et al. Scintigraphic measurement of regional gut transit in idiopathic constipation. Gastroenterology 1991; 101: 107-15.
92. Verne GN, Hocking MP, Davis RH et al. Long-term response to subtotal colectomy in colonic inertia. J Gastrointest Surg 2002; 6: 738-44.
93. Maqbool S, Parkman HP, Friedenberg FK. Wireless capsule motility: comparison of the SmartPill® GI monitoring system with scintigraphy for measuring whole gut transit Dig Dis Sci 2009; 54: 2167-74.
94. Rao S, Valestin J, Attaluri A, Wilding G, Semler JR. Inter-observer agreement for regional and whole gut transit measurement by wireless motility capsule in health, gastroparesis and constipation. Am J Gastroenterol 2010; 105: 1161.
95. Ringel Y, Gelfond D, Galanko JA et al. Alterations in intestinal transit in subgroups of patients with functional bowel disorders and healthy controls - a wireless motility capsule study. Am J Gastroenterol 2010; 105: 1159.
96. Saad R, Rao SS, Koch KL et al. Do stool form and frequency correlate with whole gut and colonic transit? Results from a multicenter study in constipated individuals and healthy controls Am J Gastroenterol 2010; 105: 403-11.
97. Lee A, Michalek W, Wiener SM, Kuo B. Clinical impact of a wireless motility capsule - a retrospective review. Gastroenterology 2010; 138: T1067.